Pharmaceuticals APAC News & Press Release Distribution

Pharmaceuticals

All
Global

Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry

The Frost Radar benchmarks the top 16 companies in the market excelling at growth and innovation SANTA CLARA, California, June 10, 2020 /PRNewswire/ -- Frost & Sullivan's Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry Radar has identified that organizations' need to mi...

2020-06-10 00:41 1086

Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry

WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States

CRANBURY, NJ and SHANGHAI, June 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has signed a 10-year lease for a clinical manufacturing facility (MFG18) inCranbury, New Jersey. The new clin...

2020-06-09 08:00 2207

Update: Deadline To File Claims Against Purdue Pharma L.P. Has Been Extended To July 30, 2020

NEW YORK, June 5, 2020 /PRNewswire/ -- The following is being issued by Prime Clerk LLC. In light of the ongoing COVID-19 pandemic, the U.S. Bankruptcy Court for the Southern District ofNew York has granted a 30-day extension of the deadline to file a claim against Purdue Pharma L.P.,1 including...

2020-06-05 01:19 2888

IPP Announces AGC Biologics Acquisition of AstraZeneca Boulder, CO Plant

PRINCETON JUNCTION, New Jersey, June 4, 2020 /PRNewswire/ -- International Process Plants (IPP), a global buyer and seller of pharmaceutical and biopharmaceutical manufacturing facilities and equipment, announced its client AGC Biologics' successful Q2/20 purchase of a state-of-the-art commercial...

2020-06-04 21:34 3024

Servier Completes the Acquisition of Symphogen

PARIS, June 4, 2020 /PRNewswire/ -- Servier, an independent international pharmaceutical company, today announced that it has completed the acquisition of Symphogen A/S. Symphogen will now function as Servier's antibody center of excellence across multiple therapeutic areas, including oncology. ...

2020-06-04 21:30 2674

Press Launch of hVIVO COVID Clear Test, the Most Accurate Antibody Test Available to UK Employers to Help Get People Back to Work

Thursday 4 June 2020, 11am at hVIVO's world leading virology clinic in Whitechapel,East London We are making available for the first time on demand antibody testing direct to large employer groups in the UK We are also seeking channel partners to make testing available through GP networks, nurs...

2020-06-04 14:00 3322

Novavax Selects AGC Biologics to Manufacture Matrix-M™ Adjuvant for Novel COVID-19 Vaccine

AGC Biologics partners with Novavax to produce NVX-CoV2373 component SEATTLE, June 3, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced that it will partner withNovavax, Inc. (NASDAQ: NVAX), a late-stage biot...

2020-06-03 19:00 3178

Toni Nesci Named Head of Mayne Contract Services and New Website Launched

ADELAIDE, Australia, June 3, 2020 /PRNewswire/ -- Toni Nesci has been appointed Head of Mayne Contract Services, a division of the Mayne Pharma family. Mayne Contract Services, based in Salisbury,South Australia is the full-service pharmaceutical development and manufacturing business unit create...

2020-06-03 10:39 2476

Eleva's Drug Candidate to Be Examined for Use in COVID-19 Treatment

FREIBURG, Germany, June 3, 2020 /PRNewswire/ -- Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the co...

2020-06-03 10:00 1683

Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study

SUZHOU, China, June 3, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announces...

2020-06-03 07:30 6734

Technopath Clinical Diagnostics Launches the First Not-For-Profit COVID-19 Antibody Testing Initiative to Support Companies in Ireland

BALLINA (County Tipperary), Ireland, June 2, 2020 /PRNewswire/ -- Technopath Clinical Diagnostics today announced that it is rolling out COVID-19 antibody testing inIreland to help businesses navigate a safer workplace re-entry. This initiative will provide key services to all industries and will...

2020-06-02 19:00 2871

QPS Awarded Two 2020 CRO Leadership Awards

NEWARK, Delaware, June 2, 2020 /PRNewswire/ -- QPS is a GLP/GCP-compliant and CLIA-certified contract research organization (CRO) delivering discovery, preclinical, and clinical drug development services since 1995. An award-winning leader focused on bioanalytics and clinical trials, QPS, has be...

2020-06-02 18:55 2798

Innovent Announced the Preliminary Results of the Anti-PD-1/PD-L1 Bispecific Antibody IBI318 in a Phase 1 Clinical Study

SUZHOU, China, June 2, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, announced the ...

2020-06-02 07:30 6137

AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings

AGC Biologics acquires Boulder, Colorado U.S.A. facility to increase global capacity and extend manufacturing scale SEATTLE, June 2, 2020 /PRNewswire/ -- AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the...

2020-06-02 06:00 3333

AGC Biologics Acquires Commercial Facility, Expanding Global Service Offerings

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

SHANGHAI, June 1, 2020 /PRNewswire/ -- Luye Pharma Group (Luye Pharma) today held a special signing ceremony as part of the "We Care About Mental Health" initiative, marking the start of three new strategic partnerships across the region. As part of the initiative, Luye Pharma granted Alvogen Kor...

2020-06-01 15:22 7902

Luye Pharma Enters Distribution and Marketing Partnerships in South Korea, Hong Kong, and Thailand for Seroquel® and Seroquel XR®

Henlius and Accord Receive Positive CHMP Opinion for Oncology Biosimilar, HLX02 (Trastuzumab)

SHANGHAI, June 1, 2020 /PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) and Accord Healthcare Limited (Accord) jointly announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing aut...

2020-06-01 13:48 3553

Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal

SYDNEY, June 1, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share a poster presentation of interim data from the ongoing phase II study of paxalisib (formerly GDC-0084) in glioblastoma, the most comm...

2020-06-01 08:45 5116

Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announced ...

2020-06-01 07:30 5163

Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma

SUZHOU, China, June 1, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines, jointly announced with Eli Lilly and Company (Lilly) (NYSE: LLY) the research results of TY...

2020-06-01 07:30 5274

Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma

2020-06-01 07:30 5477

1 ... 170 171 172173174 175 176 ... 187